Expiratory Muscle Training in Bronchiectasis

Pamukkale University

Status: Completed

Conditions: Bronchiectasis

Treatments: Other: EMST150 (Expiratory muscle training); Other: Sham EMST150 (Expiratory muscle training)

Study type: Interventional

Funder types: Other

Identifiers

NCT05408455

646873

Details and patient eligibility

About

Reduced exercise tolerance is commonly reported in patients with bronchiectasis. The purpose of this study is to evaluate the effects of expiratory muscle training (EMT) and sham EMT (control) on exercise capacity, respiratory function and respiratory muscle strength, cough strength and health related quality of life in patients with bronchiectasis.

Full description

Disruption of the mucociliary clearance mechanism in patients with bronchiectasis leaves the lungs vulnerable. With the accumulation of secretions, a vicious cycle of bacterial infection and inflammation begins. Intense inflammation causes damage and bronchial wall weakness. Problems arise with effective coughing. This leads to decreased clearance of secretions, resulting in decreased expiratory flow. Symptoms of bronchiectasis; often productive cough, dyspnea, fatigue and wheezing. Altered pulmonary mechanics, inadequate gas exchange, decreased muscle mass, and accompanying psychological problems can cause dyspnea and decreased exercise capacity, thus reducing quality of life. Exercise capacity may also decrease in individuals with bronchiectasis due to increased dyspnea perception and limitation of expiratory flow. The need for safe and viable exercise interventions to reduce the burden of the disease is evident in individuals with bronchiectasis. Respiratory muscle training is applied by using skeletal muscle training principles in order to increase respiratory muscle strength and endurance, to correct the length-tension relationship of respiratory muscles and to increase respiratory capacity. Decreased expiratory muscle strength is associated with decreased quality of life and exercise tolerance. In addition, in a study, it was shown that in addition to expiratory muscle weakness, expiratory muscle endurance decreases in respiratory patients. This decrease is closely related to the severity of airway obstruction and the decrease in the strength of other muscle groups.

In order to meet the increased metabolic needs during exercise and to keep gas exchange at a sufficient level, patients with bronchiectasis; they must increase minute ventilation as appropriate. These patients with expiratory flow limitation at rest breathe at higher lung volumes to increase ventilation during exercise, and as a result, adverse conditions such as worsening of dynamic hyperinflation, increased intrinsic PEEP, increased workload on respiratory muscles and dyspnea are observed. As a result, these patients cannot achieve high levels of tidal volume and ventilation. In addition, significantly reduced maximal voluntary ventilation in patients with flow-limited bronchiectasis; It is also related to airway obstruction and mechanical deterioration. Decreased exercise capacity has also been shown to be associated with peak exercise desaturation. Those with abnormal lung mechanics (low FEV1, FVC, and tidal expiratory flow limitation) and high dyspnea score measured by MRC reflect a decrease in exercise capacity. In a study in bronchiectasis, maximal inspiratory and maximal expiratory respiratory muscle strengths evaluated with an intraoral pressure measurement device had similar demographic characteristics. significantly lower than in healthy individuals. However, in the respiratory muscle trainings, inspiratory muscle training was emphasized and expiratory muscle training was never given.

Enrollment: 29 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Clinically stable patients who do not meet the definition of exacerbation,
• Those with a diagnosis of non-CF bronchiectasis,
• Patients are between the ages of 18-70
• Patients without acute and/or chronic respiratory failure,
• Patients who do not have any contraindications for the physiotherapy method to be applied.

Exclusion criteria

• Those with a history of pneumothorax,
• Patients younger than 18 years
• Patients older than 70 years
• Presence of cor pulmonale and/or heart failure,
• Patients with hemoptysis,
• Those with a recent history of acute myocardial infarction,
• Presence of spinal cord injury,
• Those with unstable intervertebral disc, rib fracture,
• Patients with severe osteoporosis,
• Those who had an infective exacerbation during the physiotherapy application period,
• Those who are found to have respiratory distress that will require hospitalization,
• If there is a wound in the application area,
• If there is infection or hemorrhage in the application area

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

29 participants in 2 patient groups

EMST (Expiratory Muscle Streght Training) group

Experimental group

Description:

EMST at a pressure value between 50-75% will be applied for 8 weeks, 3 days a week and 24 sessions in total.

Treatment:

Other: EMST150 (Expiratory muscle training)

Sham EMST Group

Sham Comparator group

Description:

EMST without threshold loading will be applied for 8 weeks, 3 days a week and 24 sessions in total.

Treatment:

Other: Sham EMST150 (Expiratory muscle training)